Cynthia Bedell

A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors

John Nemunaitis, Alex W. Tong, Michael Nemunaitis et al. · Molecular Therapy · 2009 · 267 citations · Full text

Medicine, Molecular Medicine, Oncology +13

Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors

Neil Senzer, John Nemunaitis, Derek Nemunaitis et al. · Molecular Therapy · 2013 · 242 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer

Neil Senzer, Minal Barve, Joseph A. Kuhn et al. · Molecular Therapy · 2011 · 195 citations · Full text

Medicine, Immunology, Oncology +17

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

Geoffrey I. Shapiro, Jordi Rodón, Cynthia Bedell et al. · Clinical Cancer Research · 2013 · 149 citations

Medicine, Pharmacokinetics, Pharmacology +15

Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma

David S. Hong, Razelle Kurzrock, Jennifer J. Wheler et al. · Clinical Cancer Research · 2015 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17